139 related articles for article (PubMed ID: 592558)
1. Effects of a 2-substituted adenosine derivative, 2-(p-methoxyphenyl)-adenosine (CV-1674) on coronary and cardiohemodynamics, and myocardial energetics.
Hirata M; Kawazoe K; Tanabe M; Kikuchi K
Jpn J Pharmacol; 1977 Oct; 27(5):689-700. PubMed ID: 592558
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
3. Adenosine on myocardial oxygen consumption.
Gross GJ; Hardman HF; Warltier DC
Br J Pharmacol; 1976 Jul; 57(3):409-12. PubMed ID: 974320
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
Tanabe M; Terashita Z; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
[TBL] [Abstract][Full Text] [Related]
5. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
6. Comparative hemodynamic effects of coronary vasodilators and contrast material on the normal and ischemic canine myocardium: determination of the optimal agent for clinical augmentation of coronary blood flow.
Higgins CB; Bookstein JJ
Invest Radiol; 1977; 12(4):299-306. PubMed ID: 407173
[TBL] [Abstract][Full Text] [Related]
7. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
Greenberg S; Touhey B; Paul J
Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-phenylaminoadenosine (CV-1808) on ischemic ST-segment elevation in anesthetized dogs.
Matsumoto N; Kawazoe K; Tanabe M; Imamoto T; Fujiwara S; Hirata M
J Cardiovasc Pharmacol; 1981; 3(6):1184-92. PubMed ID: 6173517
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of endothelin and Bay k 8644 on cardiohemodynamics in anesthetized pigs.
Adachi H; Shoji T; Goto K
Eur J Pharmacol; 1991 Jan; 193(1):57-65. PubMed ID: 1710988
[TBL] [Abstract][Full Text] [Related]
10. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist.
Glover DK; Ruiz M; Yang JY; Koplan BA; Allen TR; Smith WH; Watson DD; Barrett RJ; Beller GA
Circulation; 1996 Oct; 94(7):1726-32. PubMed ID: 8840867
[TBL] [Abstract][Full Text] [Related]
12. Coronary and cardiohemodynamic effects of 2-phenylamino-adenosine (CV-1808) in anesthetized dogs and cats.
Kawazoe K; Matsumoto N; Tanabe M; Fujiwara S; Yanagimoto M; Hirata M; Kikuchi K
Arzneimittelforschung; 1980; 30(7):1083-7. PubMed ID: 7191290
[No Abstract] [Full Text] [Related]
13. Myocardial imaging in dogs treated with grisorixin: relationship between thallium-201 uptake and coronary blood flow.
Moins N; Gachon P; Maublant J
J Nucl Med; 1982 Apr; 23(4):330-6. PubMed ID: 7069497
[TBL] [Abstract][Full Text] [Related]
14. Effects of a 2',3',5'-substituted adenosine derivative on systemic and coronary hemodynamics and on cardiac metabolism in the anesthetized dog.
Schütz W; Raberger G; Kraupp O
Arzneimittelforschung; 1978; 28(11):2079-82. PubMed ID: 582910
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
18. Adenosine for controlled hypotension: systemic compared with intracoronary infusion in dogs.
Sidi A; Rush W
Anesth Analg; 1992 Sep; 75(3):319-28. PubMed ID: 1510251
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenosine on myocardial oxygen balance.
Gross GJ; Warltier DC; Hardman HF
J Pharmacol Exp Ther; 1976 Feb; 196(2):445-54. PubMed ID: 1255487
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine-induced controlled hypotension on canine myocardial performance, blood flow and metabolism.
Owall A; Sollevi A; Rudehill A; Sylvén C
Acta Anaesthesiol Scand; 1986 Feb; 30(2):167-72. PubMed ID: 3705905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
